TG Therapeutics, Inc. (TGTX) Revenue History
TG Therapeutics, Inc. (TGTX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $152.38K |
| 2017-12-31 | $152.00K |
| 2018-12-31 | $152.00K |
| 2019-12-31 | $152.00K |
| 2020-12-31 | $152.00K |
| 2021-12-31 | $6.69M |
| 2022-12-31 | $2.79M |
| 2023-12-31 | $233.66M |
| 2024-12-31 | $329.00M |
| 2025-12-31 | $616.29M |
How TGTX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | $673.00M |
| AXSM | Axsome Therapeutics Inc. | $638.50M |
| AZTA | Azenta Inc. | $593.82M |
| ATRC | AtriCure Inc. | $534.53M |
| VCYT | Veracyte Inc. | $517.14M |
These are five companies in the same sector as TGTX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get TG Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("TGTX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TGTX | $54.52 | +0.46% | 1.30M |
| 3 | ||||
| 4 | ||||
| 5 |